• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2019 o Market outlook: Forecast for 2019 - 2024 • Five Forces Analysis o Five Forces Summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Product o Market segments o Comparison by Product placement o E-cigarette - Market size and forecast 2019-2024 o NRT - Market size and forecast 2019-2024 o Drug therapy - Market size and forecast 2019-2024 o Market opportunity by Product • Customer landscape o Overview • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o APAC - Market size and forecast 2019-2024 o South America - Market size and forecast 2019-2024 o MEA - Market size and forecast 2019-2024 o Key leading countries o Market opportunity by geography • Drivers, Challenges, and Trends o Market drivers o Volume driver - Demand led growth o Volume driver - Supply led growth o Volume driver - External factors o Volume driver - Demand shift in adjacent markets o Price driver - Inflation o Price driver - Shift from lower to higher priced units o Market challenges o Market trends • Vendor Landscape o Overview o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o British American Tobacco Plc o Cipla Ltd. o Dr. Reddy's Laboratories Ltd. o GlaxoSmithKline Plc o Imperial Brands Plc o Japan Tobacco Inc. o Johnson & Johnson Services Inc. o JUUL Labs Inc. o Pfizer Inc. o Philip Morris International Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibits • 1.Key Finding 1 • 2.Key Finding 2 • 3.Key Finding 3 • 4.Key Finding 4 • 5.Key Finding 5 • 6.Key Finding 6 • 7.Key Finding 7 • 8.Market in focus • 9.Parent market • 10.Market characteristics • 11.Product / Service portfolio of key vendors included in the market definition • 12.Market segments • 13.Global - Market size and forecast 2019 - 2024 ($ billion) • 14.Global market: Year-over-year growth 2019 - 2024 (%) • 15.Five forces analysis 2019 & 2024 • 16.Bargaining power of buyers • 17.Bargaining power of suppliers • 18.Threat of new entrants • 19.Threat of substitutes • 20.Threat of rivalry • 21.Market condition - Five forces 2019 • 22.Product placement - Market share 2019-2024 (%) • 23.Comparison by Product placement • 24.E-cigarette - Market size and forecast 2019-2024 ($ billion) • 25.E-cigarette - Year-over-year growth 2019-2024 (%) • 26.NRT - Market size and forecast 2019-2024 ($ billion) • 27.NRT - Year-over-year growth 2019-2024 (%) • 28.Drug therapy - Market size and forecast 2019-2024 ($ billion) • 29.Drug therapy - Year-over-year growth 2019-2024 (%) • 30. Market opportunity by Product • 31.Customer landscape • 32.Market share by geography 2019-2024 (%) • 33.Geographic comparison • 34.North America - Market size and forecast 2019-2024 ($ billion) • 35.North America - Year-over-year growth 2019-2024 (%) • 36.Europe - Market size and forecast 2019-2024 ($ billion) • 37.Europe - Year-over-year growth 2019-2024 (%) • 38.APAC - Market size and forecast 2019-2024 ($ billion) • 39.APAC - Year-over-year growth 2019-2024 (%) • 40.South America - Market size and forecast 2019-2024 ($ billion) • 41.South America - Year-over-year growth 2019-2024 (%) • 42.MEA - Market size and forecast 2019-2024 ($ billion) • 43.MEA - Year-over-year growth 2019-2024 (%) • 44.Key leading countries • 45.Market opportunity by geography ($ billion) • 46.Impact of drivers • 47.Impact of challenges • 48.Landscape disruption • 49.Industry risks • 50.Vendors covered • 51.Market positioning of vendors • 52.British American Tobacco Plc - Overview (1/3) • 53.British American Tobacco Plc - Overview (2/3) • 54.British American Tobacco Plc - Overview (3/3) • 55.British American Tobacco Plc - Product and service • 56.British American Tobacco Plc - Key offerings • 57.British American Tobacco Plc - Key customers • 58.British American Tobacco Plc - Segment focus • 59.Cipla Ltd. - Overview (1/3) • 60.Cipla Ltd. - Overview (2/3) • 61.Cipla Ltd. - Overview (3/3) • 62.Cipla Ltd. - Business segments • 63.Cipla Ltd. - Key offerings • 64.Cipla Ltd. - Key customers • 65.Cipla Ltd. - Segment focus • 66.Dr. Reddy's Laboratories Ltd. - Overview (1/3) • 67.Dr. Reddy's Laboratories Ltd. - Overview (2/3) • 68.Dr. Reddy's Laboratories Ltd. - Overview (3/3) • 69.Dr. Reddy's Laboratories Ltd. - Business segments • 70.Dr. Reddy's Laboratories Ltd. - Key offerings • 71.Dr. Reddy's Laboratories Ltd. - Key customers • 72.Dr. Reddy's Laboratories Ltd. - Segment focus • 73.GlaxoSmithKline Plc - Overview (1/3) • 74.GlaxoSmithKline Plc - Overview (2/3) • 75.GlaxoSmithKline Plc - Overview (3/3) • 76.GlaxoSmithKline Plc - Business segments • 77.GlaxoSmithKline Plc - Key offerings • 78.GlaxoSmithKline Plc - Key customers • 79.GlaxoSmithKline Plc - Segment focus • 80.Imperial Brands Plc - Overview (1/3) • 81.Imperial Brands Plc - Overview (2/3) • 82.Imperial Brands Plc - Overview (3/3) • 83.Imperial Brands Plc - Business segments • 84.Imperial Brands Plc - Key offerings • 85.Imperial Brands Plc - Key customers • 86.Imperial Brands Plc - Segment focus • 87.Japan Tobacco Inc. - Overview (1/3) • 88.Japan Tobacco Inc. - Overview (2/3) • 89.Japan Tobacco Inc. - Overview (3/3) • 90.Japan Tobacco Inc. - Business segments • 91.Japan Tobacco Inc. - Key offerings • 92.Japan Tobacco Inc. - Key customers • 93.Japan Tobacco Inc. - Segment focus • 94.Johnson & Johnson Services Inc. - Overview (1/3) • 95.Johnson & Johnson Services Inc. - Overview (2/3) • 96.Johnson & Johnson Services Inc. - Overview (3/3) • 97.Johnson & Johnson Services Inc. - Business segments • 98.Johnson & Johnson Services Inc. - Key offerings • 99.Johnson & Johnson Services Inc. - Key customers • 100.Johnson & Johnson Services Inc. - Segment focus • 101.JUUL Labs Inc. - Overview (1/3) • 102.JUUL Labs Inc. - Overview (2/3) • 103.JUUL Labs Inc. - Overview (3/3) • 104.JUUL Labs Inc. - Product and service • 105.JUUL Labs Inc. - Key offerings • 106.JUUL Labs Inc. - Key customers • 107.JUUL Labs Inc. - Segment focus • 108.Pfizer Inc. - Overview (1/3) • 109.Pfizer Inc. - Overview (2/3) • 110.Pfizer Inc. - Overview (3/3) • 111.Pfizer Inc. - Business segments • 112.Pfizer Inc. - Key offerings • 113.Pfizer Inc. - Key customers • 114.Pfizer Inc. - Segment focus • 115.Philip Morris International Inc. - Overview (1/3) • 116.Philip Morris International Inc. - Overview (2/3) • 117.Philip Morris International Inc. - Overview (3/3) • 118.Philip Morris International Inc. - Business segments • 119.Philip Morris International Inc. - Key offerings • 120.Philip Morris International Inc. - Key customers • 121.Philip Morris International Inc. - Segment focus • 122.Currency conversion rates for US$ • 123.Research Methodology • 124.Validation techniques employed for market sizing • 125.Information sources • 126.List of abbreviations

British American Tobacco Plc,Cipla Ltd.,Dr. Reddy's Laboratories Ltd.,GlaxoSmithKline Plc,Imperial Brands Plc,Japan Tobacco Inc.,Johnson & Johnson Services Inc.,JUUL Labs Inc.,Pfizer Inc.,Philip Morris International Inc.